2024
THE USE OF COMBINED ORAL CONTRACEPTIVE PILL VS. PROGESTIN ONLY PILL PRIOR TO A SINGLE EUPLOID FROZEN EMBRYO TRANSFER CYCLE DOES NOT IMPACT CLINICAL OUTCOMES
Sachdev D, George L, Gill P, Seli E, Werner M. THE USE OF COMBINED ORAL CONTRACEPTIVE PILL VS. PROGESTIN ONLY PILL PRIOR TO A SINGLE EUPLOID FROZEN EMBRYO TRANSFER CYCLE DOES NOT IMPACT CLINICAL OUTCOMES. Fertility And Sterility 2024, 122: e395. DOI: 10.1016/j.fertnstert.2024.08.204.Peer-Reviewed Original Research
2021
Noninvasive preimplantation genetic testing for aneuploidy exhibits high rates of deoxyribonucleic acid amplification failure and poor correlation with results obtained using trophectoderm biopsy
Hanson BM, Tao X, Hong KH, Comito CE, Pangasnan R, Seli E, Jalas C, Scott RT. Noninvasive preimplantation genetic testing for aneuploidy exhibits high rates of deoxyribonucleic acid amplification failure and poor correlation with results obtained using trophectoderm biopsy. Fertility And Sterility 2021, 115: 1461-1470. PMID: 33745720, DOI: 10.1016/j.fertnstert.2021.01.028.Peer-Reviewed Original ResearchMeSH KeywordsAneuploidyBlastocystCulture MediaEmbryo Culture TechniquesEmbryo ImplantationEmbryo TransferFemaleFertilityHigh-Throughput Nucleotide SequencingHumansInfertilityLive BirthMaleNoninvasive Prenatal TestingNucleic Acid Amplification TechniquesPredictive Value of TestsPregnancyPregnancy RatePreimplantation DiagnosisReproducibility of ResultsSperm Injections, IntracytoplasmicTime FactorsTreatment OutcomeWhole Genome SequencingConceptsPreimplantation genetic testingGenetic testingBiopsy resultsProspective cohort study SETTINGTrophectoderm biopsyTE biopsyNoninvasive preimplantation genetic testingCohort study SETTINGNext-generation sequencingHigh ratePrimary outcomeClinical outcomesMAIN OUTCOMEBiopsyStudy settingAmplification failureDiscordant resultsClinical applicabilityPrivate practiceNiPGTAvailable kitsCulture mediumShort durationOutcomesCulture medium samplesThe Appraisal of Body Content (ABC) trial: Increased male or female adiposity does not significantly impact in vitro fertilization laboratory or clinical outcomes
Kim J, Patounakis G, Juneau C, Morin S, Neal S, Bergh P, Seli E, Scott R. The Appraisal of Body Content (ABC) trial: Increased male or female adiposity does not significantly impact in vitro fertilization laboratory or clinical outcomes. Fertility And Sterility 2021, 116: 444-452. PMID: 33581854, DOI: 10.1016/j.fertnstert.2020.12.037.Peer-Reviewed Original ResearchConceptsBody mass indexBioelectric impedance analysisLive birth rateLow birth weightClinical outcomesMiscarriage rateBlastocyst formation rateEuploidy rateImplantation rateBirth weightLow birth weight/Low birth weight infantsNormal weight patientsBirth weight infantsProspective cohort studyImpact of obesityFertilization laboratoryBirth rateFertilization rateBF categoriesWeight patientsMaternal obesityWeight infantsCohort studyObese women
2020
A multicenter, prospective, blinded, nonselection study evaluating the predictive value of an aneuploid diagnosis using a targeted next-generation sequencing–based preimplantation genetic testing for aneuploidy assay and impact of biopsy
Tiegs AW, Tao X, Zhan Y, Whitehead C, Kim J, Hanson B, Osman E, Kim TJ, Patounakis G, Gutmann J, Castelbaum A, Seli E, Jalas C, Scott RT. A multicenter, prospective, blinded, nonselection study evaluating the predictive value of an aneuploid diagnosis using a targeted next-generation sequencing–based preimplantation genetic testing for aneuploidy assay and impact of biopsy. Fertility And Sterility 2020, 115: 627-637. PMID: 32863013, DOI: 10.1016/j.fertnstert.2020.07.052.Peer-Reviewed Original ResearchConceptsPreimplantation genetic testingSustained implantationPredictive valueGenetic testingClinical outcomesTrophectoderm biopsyAge-matched control groupImpact of biopsyPGT-A resultsAntral follicle countRecurrent pregnancy lossBody mass indexDetectable adverse impactAneuploid resultsSecondary outcomesFertilization cyclesFollicle countPrimary outcomeMass indexUsable blastocystsBlastocyst transferFertility centerPregnancy lossClinical error ratesStudy groupKey metrics and processes for validating embryo diagnostics
Jalas C, Seli E, Scott RT. Key metrics and processes for validating embryo diagnostics. Fertility And Sterility 2020, 114: 16-23. PMID: 32505382, DOI: 10.1016/j.fertnstert.2020.04.053.Peer-Reviewed Original Research
2012
Embryo assessment strategies and their validation for clinical use
Uyar A, Seli E. Embryo assessment strategies and their validation for clinical use. Current Opinion In Obstetrics & Gynecology 2012, 24: 141-150. PMID: 22487726, DOI: 10.1097/gco.0b013e328352cd17.Peer-Reviewed Original Research